Mapping large numbers of results may take a few moments.
Search Results
Showing 501 - 517 of 517 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Vital Plan Inc. | Activity: Research and Development | Company Description Vital Plan formulates and produces natural supplements and herbal therapies that support immune health, microbiome balance, and healthy aging. | Location Raleigh | |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill | |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham | |
Company Worldwide Clinical Trials Inc. | Activity: Contract Research and Testing | Company Description Worldwide Clinical Trials provides phase one through phase four drug development services to the pharmaceutical and biotechnology industries. | Location Research Triangle Park | |
Company Xenobiotic Detection Systems International Inc. | Activity: Contract Research and Testing | Company Description Xenobiotic Detection Systems offers patented bioassays to facilitate assessment of environmental and human health risks. | Location Durham | |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary | |
Company Xona Microfluidics Inc. | Activity: Research and Development | Company Description Xona Microfluidics develops and manufactures microfluidic platforms for neuroscience research. | Location Research Triangle Park | |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary | |
Company Xyzagen Inc. | Activity: Contract Research and Testing | Company Description Xyzagen is a non-GLP LC-MS/MS bioanalytical lab with rodent in vivo pharmacokinetics and pharmacology research vivarium. Xyzagen also offers clinical pharmacology/pharmokinetics and GLP toxicokinetic support. | Location Pittsboro | |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill | |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill | |
Company Zoetis Inc. | Activity: Production and Manufacturing | Company Description Zoetis develops and manufactures vaccines and medications for animal health. The Durham site develops and manufactures high-throughput automation biodevices for the poultry industry, including in ovo vaccination technology. | Location Durham | |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh | |
Company Zorbius Biopharma Inc. | Activity: Contract Research and Testing | Company Description Zorbius Biopharma provides analytical, formulation and nanotechnology-related services to pharmaceutical, biotech and medical device companies. | Location Morrisville | |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park | |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham | |
Company Zymtronix Inc. | Activity: Research and Development | Company Description Zymtronix provides technology that can enable and improve any biocatalytic reaction involving single enzymes or cell-free systems of multiple enzymes. Zymtronix offers solutions for various industries, including agriculture, life sciences, and ingredients. | Location Research Triangle Park |